Clinical response to 131I-labeled chimeric 81C6 mAb
Patient no. . | Disease . | No. prior regimens . | No. prior cycles . | Response . |
|---|---|---|---|---|
| 1 | CLL/SLL | 3 | 13 | SD |
| 2 | DLCL | 4 | 11 | SD |
| 3 | Transformed NHL | 2 | 7 | SD |
| 4 | MALT lymphoma | 2 | 7 | CRu (6 mo) |
| 5 | Transformed NHL | 4 | 14 | SD |
| 6 | Follicular | 4 | 18 | SD |
| 7 | DLCL | 2 | 8 | SD |
| 8 | DLCL | 5 | 14 | SD |
| 9 | CLL/SLL | 3 | 8 | PR (continues > 8 mo) |
Patient no. . | Disease . | No. prior regimens . | No. prior cycles . | Response . |
|---|---|---|---|---|
| 1 | CLL/SLL | 3 | 13 | SD |
| 2 | DLCL | 4 | 11 | SD |
| 3 | Transformed NHL | 2 | 7 | SD |
| 4 | MALT lymphoma | 2 | 7 | CRu (6 mo) |
| 5 | Transformed NHL | 4 | 14 | SD |
| 6 | Follicular | 4 | 18 | SD |
| 7 | DLCL | 2 | 8 | SD |
| 8 | DLCL | 5 | 14 | SD |
| 9 | CLL/SLL | 3 | 8 | PR (continues > 8 mo) |
CLL indicates chronic lymphocytic leukemia; SLL, small lymphocytic lymphoma; SD, stable disease; DLCL, diffuse large cell lymphoma; MALT, mucosa-associated lymphoid tissue lymphoma; CRu, complete remission unconfirmed; PR, partial remission.